After alcohol, marijuana is the most commonly used recreational substance among U.S. adults and adolescents. Up to 22 million Americans 12 or older use cannabis. In a 2022 survey by the National Institute on Drug Abuse, 0.7% ...
Oct 11, 2023
0
28
A Johns Hopkins Children's Center study of medical records concludes that delaying surgical treatment of the anterior cruciate ligament, or ACL, in some children is associated with a higher risk of new tears in the meniscus ...
Oct 10, 2023
0
6
Cancer arises when cells accumulate enough damage to change their normal behavior. The likelihood of accruing damage increases with age because the safeguards in your genetic code that ensure cells function for the greater ...
Oct 10, 2023
0
1
The emerging field of medical cannabinoids has experienced a breakthrough in epilepsy and seizure disorders. A team led by D. Samba Reddy, Ph.D., RPh, a Regents Professor in the Department of Neuroscience and Experimental ...
Oct 5, 2023
0
22
Spending on mental health services for children and adolescents has risen by more than one-quarter since the beginning of the COVID-19 pandemic, continuing to rise even as the use of telehealth plateaued, according to a new ...
Oct 3, 2023
0
23
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...
Oct 2, 2023
0
8
Epilepsy is one of the more common neurologic disorders in children. About 1 in 26 people have epilepsy, and 1 in 10 people will have at least one seizure in their lifetime.
Sep 29, 2023
0
1
Some specialties have made significant improvements in academic medial leadership diversity since 2007, according to a study published online Sept. 25 in JAMA Network Open.
Sep 27, 2023
0
3
Alicia Persaud, MPH, a graduate research assistant in the Division of Pediatrics at Massachusetts General Hospital is the lead author; and Lauren Fiechtner, MD, director of the Center for Pediatric Nutrition at Mass General ...
Sep 27, 2023
0
1
Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a study ...
Sep 21, 2023
0
16
